WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced its development and commercialization partner, Torii Pharmaceutical Co. Ltd. ("Torii"), submitted a New Drug Application ("NDA") of TO-208 (referred to as VP-102 and marketed as YCANTH® in the U.S.) for the treatment of Molluscum Contagiosum ("molluscum") in Japan.
"Torii continues to be an outstanding partner in advancing TO-208 for the treatment of molluscum, and today's NDA submission represents the next critical milestone towards bringing to market the first therapeutic for addressing this indication in Japan," said Jayson Rieger, Ph.D., MBA, President and Chief Executive Officer of Verrica. "With an estimated prevalence of approximately 1.6 million cases, molluscum represents a large and underserved patient population in Japan, and we believe Torii's therapeutic expertise and commercial infrastructure in dermatology will maximize the opportunity to address this significant unmet need."
kAm%~\a_g :D 2 D<:? 5:D62D6 EC62E>6?E 5CF8 42?5:52E6 4@?E2:?:?8 42?E92C:5:? 2D 2? 24E:G6 :?8C65:6?E] x? E96 !92D6 b 4=:?:42= DEF5J @7 %~\a_g :? A2E:6?ED H:E9 >@==FD4F> 4@?E28:@DF> W≥a J62CD @=5X :? y2A2?[ E96 AC:>2CJ 6?5A@:?E @7 677:424J 92D >6E DFA6C:@C:EJ E@ E96 G69:4=6] uFCE96C>@C6[ E96 D276EJ AC@7:=6 @7 %~\a_g :? E96 DEF5J H2D 4@?D:DE6?E E@ AC:@C DEF5:6D :? E96 &?:E65 $E2E6D 2?5 E96C6 H6C6 ?@ @3D6CG65 :DDF6D @7 E@=6C23:=:EJ 7@C E96 2AA=:42E:@?]k^Am kAm%@C:: 2?5 '6CC:42 6I64FE65 2? 6I4=FD:G6 =:46?D6 28C66>6?E 7@C E96 56G6=@A>6?E 2?5 4@>>6C4:2=:K2E:@? @7 %~\a_g 7@C E96 EC62E>6?E @7 >@==FD4F> 2?5 4@>>@? H2CED :? y2A2? :? |2C49 a_a']k^AmkAm'6CC:42 C646:G65 >2?F724EFC:?8 2?5 >2C<6E:?8 2AAC@G2= @7 '!\'_a E@ EC62E >@==FD4F> 4@?E28:@DF> :? E96 &]$] :? yF=J a_ab] '6CC:42 92D >2C<6E65 '!\'_a F?56C E96 3C2?5 ?2>6 *rp}%w® :? E96 &]$] D:?46 pF8FDE a_ab 2?5 92D 4@>A=6E65 2 !92D6 a 4=:?:42= DEF5J @7 '!\'_a 7@C E96 EC62E>6?E @7 4@>>@? H2CED 2?5 2 !92D6 a 4=:?:42= DEF5J @7 '!\'_a 7@C E96 EC62E>6?E @7 6IE6C?2= 86?:E2= H2CED :? E96 &]$]k^AmkAmp3@FE *rp}%w® W'!\'_aXk^AmkAm*rp}%wUC68jU?3DAj:D 2 AC@AC:6E2CJ 5CF8\56G:46 4@>3:?2E:@? AC@5F4E E92E 4@?E2:?D 2 v|!\4@?EC@==65 7@C>F=2E:@? @7 42?E92C:5:? 56=:G6C65 G:2 2 D:?8=6\FD6 2AA=:42E@C E92E 2==@HD 7@C AC64:D6 E@A:42= 5@D:?8 2?5 E2C86E65 25>:?:DEC2E:@? 7@C E96 EC62E>6?E @7 >@==FD4F>] *rp}%wUC68jU?3DAj:D E96 7:CDE 2?5 @?=J 4@>>6C4:2==J 2G2:=23=6 AC@5F4E 2AAC@G65 3J E96 usp E@ EC62E 25F=E 2?5 A65:2EC:4 A2E:6?ED EH@ J62CD @7 286 2?5 @=56C H:E9 >@==FD4F> 4@?E28:@DF> U>52D9j 2 4@>>@?[ 9:89=J 4@?E28:@FD D<:? 5:D62D6 E92E 27764ED 2? 6DE:>2E65 D:I >:==:@? A6@A=6 :? E96 &?:E65 $E2E6D[ AC:>2C:=J 49:=5C6?] pAAC@G2= @7 *rp}%wUC68jU?3DAjH2D 32D65 FA@? E96 A@D:E:G6 C6DF=ED 7C@> EH@ !92D6 b 4=:?:42= EC:2=D :? 2AAC@I:>2E6=J d__ A2E:6?ED H9:49 56>@?DEC2E65 E92E *rp}%wUC68jU?3DAjH2D 2 D276 2?5 67764E:G6 E96C2A6FE:4 7@C E96 EC62E>6?E @7 >@==FD4F>] pAAC@I:>2E6=J aag >:==:@? =:G6D 2C6 6=:8:3=6 E@ C646:G6 *rp}%wUC68jU?3DAj4@G6C65 3J :?DFC2?46] *rp}%wUC68jU?3DAj:D 2G2:=23=6 E@ 2== A2E:6?ED H:E9 2?5 H:E9@FE :?DFC2?46 4@G6C286 7@C Sad A6C EC62E>6?E[ 2?5 7FCE96C 7:?2?4:2= 2DD:DE2?46 :D 2G2:=23=6 7@C A2E:6?ED :? ?665] !=62D6 G:D:E k2 9C67lQ9EEAi^^*rp}%w!C@]4@>Qm*rp}%w!C@]4@>k^2m 7@C 255:E:@?2= :?7@C>2E:@?]k^AmkAm*rp}%w® D9@F=5 @?=J 36 25>:?:DE6C65 3J 2 EC2:?65 962=E942C6 AC@76DD:@?2=] *rp}%w® :D ?@E 7@C 9@>6 FD6]k^AmkAmp3@FE '6CC:42 !92C>246FE:42=D x?4]k^AmkAm'6CC:42 :D 2 56C>2E@=@8J E96C2A6FE:4D 4@>A2?J 56G6=@A:?8 >65:42E:@?D 7@C D<:? 5:D62D6D C6BF:C:?8 >65:42= :?E6CG6?E:@?D] '6CC:42'D AC@5F4E *rp}%w® W'!\'_aX W42?E92C:5:?X[ :D E96 7:CDE 2?5 @?=J 4@>>6C4:2==J 2G2:=23=6 EC62E>6?E 2AAC@G65 3J E96 usp E@ EC62E 25F=E 2?5 A65:2EC:4 A2E:6?ED EH@ J62CD @7 286 2?5 @=56C H:E9 >@==FD4F> 4@?E28:@DF>[ 2 9:89=J 4@?E28:@FD G:C2= D<:? :?764E:@? 27764E:?8 2AAC@I:>2E6=J e >:==:@? A6@A=6 :? E96 &?:E65 $E2E6D[ AC:>2C:=J 49:=5C6?] *rp}%w® W'!\'_aX :D 2=D@ :? 56G6=@A>6?E E@ EC62E 4@>>@? H2CED 2?5 6IE6C?2= 86?:E2= H2CED[ EH@ @7 E96 =2C86DE C6>2:?:?8 F?>6E ?665D :? >65:42= 56C>2E@=@8J] '6CC:42 :D 56G6=@A:?8 '!\'_b[ :ED D64@?5 42?E92C:5:?\32D65 AC@5F4E 42?5:52E6[ 7@C E96 EC62E>6?E @7 A=2?E2C H2CED] '6CC:42 92D 2=D@ 6?E6C65 2 H@C=5H:56 =:46?D6 28C66>6?E H:E9 {JE:I q:@A92C>2 p$ E@ 56G6=@A 2?5 4@>>6C4:2=:K6 '!\b'd W7@C>6C=J {%)\b'd 2?5 '!\{%)\b'dX 7@C ?@?\>6=2?@>2 D<:? 42?46CD :?4=F5:?8 32D2= 46== 42C4:?@>2 2?5 DBF2>@FD 46== 42C4:?@>2]k^AmkAmu@CH2C5\{@@<:?8 $E2E6>6?EDk^Am kAmp?J DE2E6>6?ED 4@?E2:?65 :? E9:D AC6DD C6=62D6 E92E 5@ ?@E 56D4C:36 9:DE@C:42= 724ED >2J 4@?DE:EFE6 7@CH2C5\=@@<:?8 DE2E6>6?ED 2D E92E E6C> :D 567:?65 :? E96 !C:G2E6 $64FC:E:6D {:E:82E:@? #67@C> p4E @7 'hhd] %96D6 DE2E6>6?ED >2J 36 :56?E:7:65 3J H@C5D DF49 2D "36=:6G6[" "6IA64E[" ">2J[" "A=2?[" "A@E6?E:2=[" "H:==[" 2?5 D:>:=2C 6IAC6DD:@?D[ 2?5 2C6 32D65 @? '6CC:42'D 4FCC6?E 36=:67D 2?5 6IA64E2E:@?D] %96D6 7@CH2C5\=@@<:?8 DE2E6>6?ED :?4=F56 DE2E6>6?ED 23@FE '6CC:42'D 6IA64E2E:@?D H:E9 C682C5 E@ E96 4=:?:42= 56G6=@A>6?E 2?5 A@E6?E:2= 4@>>6C4:2=:K2E:@? @7 %~\a_g 7@C E96 EC62E>6?E @7 >@==FD4F> :? y2A2?[ %@CC:'D 23:=:EJ E@ >2I:>:K6 E96 @AA@CEF?:EJ :? y2A2?[ E96 4=:?:42= 56G6=@A>6?E @7 *rp}%w W'!\'_aX 7@C 255:E:@?2= :?5:42E:@?D[ 2?5 E96 36?67:ED @7 '6CC:42'D AC@5F4E 42?5:52E6D[ :?4=F5:?8 *rp}%w W'!\'_aX] %96D6 DE2E6>6?ED :?G@=G6 C:D<D 2?5 F?46CE2:?E:6D E92E 4@F=5 42FD6 24EF2= C6DF=ED E@ 5:776C >2E6C:2==J 7C@> E9@D6 C67=64E65 :? DF49 DE2E6>6?ED] #:D<D 2?5 F?46CE2:?E:6D E92E >2J 42FD6 24EF2= C6DF=ED E@ 5:776C >2E6C:2==J :?4=F56 C:D<D 2?5 F?46CE2:?E:6D C6=2E65 E@ >2C<6E 4@?5:E:@?D[ D2E:D724E:@? @7 4FDE@>2CJ 4=@D:?8 4@?5:E:@?D C6=2E65 E@ E96 AC@A@D65 AF3=:4 @776C:?8 2?5 @E96C C:D<D 2?5 F?46CE2:?E:6D E92E 2C6 56D4C:365 :? '6CC:42'D p??F2= #6A@CE @? u@C> '_\z 7@C E96 J62C 6?565 s646>36C b'[ a_ab[ '6CC:42'D "F2CE6C=J #6A@CE @? u@C> '_\" 7@C E96 BF2CE6C 6?565 $6AE6>36C b_[ a_ac 2?5 @E96C 7:=:?8D '6CC:42 >2<6D H:E9 E96 $tr] p?J 7@CH2C5\=@@<:?8 DE2E6>6?ED DA62< @?=J 2D @7 E96 52E6 @7 E9:D AC6DD C6=62D6 2?5 2C6 32D65 @? :?7@C>2E:@? 2G2:=23=6 E@ '6CC:42 2D @7 E96 52E6 @7 E9:D C6=62D6[ 2?5 '6CC:42 2DDF>6D ?@ @3=:82E:@? E@[ 2?5 5@6D ?@E :?E6?5 E@[ FA52E6 2?J 7@CH2C5\=@@<:?8 DE2E6>6?ED[ H96E96C 2D 2 C6DF=E @7 ?6H :?7@C>2E:@?[ 7FEFC6 6G6?ED @C @E96CH:D6]k^AmkAmu~# |~#t x}u~#|p%x~}[ !{tp$t r~}%pr%ik^AmkAmx?G6DE@CDik^AmkAmz6G:? v2C5?6Ck^AmkAm{:76$4: p5G:D@CDk^AmkAmk2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2l9EK+r'!K@ch:?(;}0a+c&|9@9:"'!)bcGeKKDw*0?+?s?{|JzCp$w?G78||@'trB{!Bryge;*pJ2sazh&FrJq$+};zsa8c2*$!p$$'Fx$}c!*ep2(C~+zFt#'p'\y\bFQ C6=lQ?@7@==@HQm<82C5?6Co=:76D4:25G:D@CD]4@>k^2mk^AmkAmr9C:D r2=23C6D6k^AmkAm{:76$4: p5G:D@CDk^AmkAmk2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2ls#C3*ggFIa5KD_{b5|HIgD(+>JH#::2Ea2z0_:!8?xh@Kv~fhzafJCH6I;Crb{zgBdF@*7e~;cx;#3p@A85!0g33#*g)'J~?5;(7$>}"A(gv\rhAH{|{zx{x?Ix~#Ce>Q C6=lQ?@7@==@HQm442=23C6D6o=:76D4:25G:D@CD]4@>k^2mk^AmkAmk^AmkAmk^Am